oncos-102
targovax
['ovarian', 'oncos-102']
ludwig 's presents at #asco2022 a study he led with support from our clinical trials management team examining checkpoint blockade #immunotherapy + oncos-102 for treatment of peritoneal disease in patients with colon &amp; ovarian cancers. 
We are an international community of acclaimed scientists dedicated to preventing and controlling cancer.